Is Moderna Winning on Vaccine Efficacy?

·4-min read
Is Moderna Winning on Vaccine Efficacy?

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) hold the top spots in the coronavirus vaccine market. It reported efficacy of 85% against severe disease in clinical trials. One in particular suggests Moderna may be the best at keeping people out of the hospital.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting